{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:09:44Z","timestamp":1773277784058,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.4158\/ep14024.ra","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T21:59:07Z","timestamp":1407880747000},"page":"1084-1092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Review of Oral Cholecystographic Agents for the Management of Hyperthyroidism"],"prefix":"10.1016","volume":"20","author":[{"given":"Nicole M.","family":"Tyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy S.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP14024.RA_bb0005","first-page":"630","article-title":"Observations on a series of aryl triiodo alkanoic acid derivatives with particular reference to a new cholecystographic medium, telepaque","volume":"69","author":"Hoppe","year":"1953","journal-title":"Am J Roentgenol Radium Ther Nucl Med."},{"key":"10.4158\/EP14024.RA_bb0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM197401242900406","article-title":"Oral Cholecystography with Iopanoic Acid","volume":"290","author":"Berk","year":"1974","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14024.RA_bb0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/bmj.3.5984.630","article-title":"Hyperthyroidism after cholecystography","volume":"3","author":"Fairhurst","year":"1975","journal-title":"Br Med J."},{"key":"10.4158\/EP14024.RA_bb0020","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jcem-43-6-1203","article-title":"Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents","volume":"43","author":"Burgi","year":"1976","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jcem-46-4-691","article-title":"Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography","volume":"46","author":"Wu","year":"1978","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0030","first-page":"521","article-title":"Pathways of metabolism of thyroid hormones","volume":"34","author":"Chopra","year":"1978","journal-title":"Recent Prog Horm Res."},{"key":"10.4158\/EP14024.RA_bb0035","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1172\/JCI113479","article-title":"Dual mechanisms of regulation of type I iodothyronine 5\u2032-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents","volume":"81","author":"St Germain","year":"1988","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14024.RA_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiology.178.1.1984325","article-title":"Oral cholecystography in contemporary gallstone imaging: a review","volume":"178","author":"Maglinte","year":"1991","journal-title":"Radiology."},{"key":"10.4158\/EP14024.RA_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1210\/jcem-61-4-723","article-title":"Long term treatment of Graves\u2019 hyperthyroidism with sodium ipodate","volume":"61","author":"Shen","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-17-8-1008","article-title":"Thyroidal uptake of I131 after iopanoic acid (telepaque) in 74 subjects","volume":"17","author":"Clark","year":"1957","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI109430","article-title":"Inhibition of intrapituitary thyroxine to 3.5.3\u2032-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats","volume":"64","author":"Larsen","year":"1979","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14024.RA_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI109887","article-title":"Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates","volume":"66","author":"Kaplan","year":"1980","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14024.RA_bb0065","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1172\/JCI25083","article-title":"Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans","volume":"115","author":"Maia","year":"2005","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14024.RA_bb0070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-0178","article-title":"Sources of circulating 3,5,3\u2032-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases","volume":"92","author":"Laurberg","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0075","series-title":"Compendium of pharmaceuticals and specialties","first-page":"1293","article-title":"Acid (Telepague, Sanofi Winthrop)","author":"Iopanoic","year":"1994"},{"key":"10.4158\/EP14024.RA_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem-57-1-207","article-title":"Effects of cholecystographic agents and sulfobromophthalein on binding of thyroid hormones to serum proteins","volume":"57","author":"Felicetta","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0085","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1172\/JCI109755","article-title":"Inhibition of hepatic binding of thyroxine by cholecystographic agents","volume":"65","author":"Felicetta","year":"1980","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14024.RA_bb0090","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/endo-117-4-1639","article-title":"Multisite inhibition by ipodate of iodothyronine secretion from perfused dog thyroid lobes","volume":"117","author":"Laurberg","year":"1985","journal-title":"Endocrinology."},{"key":"10.4158\/EP14024.RA_bb0095","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI109598","article-title":"Physiological and pharmacological influences on thyroxine to 3,5,3\u2032-triiodothyronine conversion and nuclear 3,5,3\u2032-triiodothyronine binding in rat anterior pituitary","volume":"64","author":"Cheron","year":"1979","journal-title":"J Clin Invest."},{"key":"10.4158\/EP14024.RA_bb0100","first-page":"477","article-title":"Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis","volume":"92","author":"Suzuki","year":"1979","journal-title":"Acta Endocrinol (Copenh)."},{"key":"10.4158\/EP14024.RA_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-64-1-119","article-title":"Treatment of neonatal hyperthyroidism due to Graves\u2019 disease with sodium ipodate","volume":"64","author":"Karpman","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/000992289303200314","article-title":"Treatment of neonatal Graves\u2019 disease with sodium ipodate. A case report","volume":"32","author":"Joshi","year":"1993","journal-title":"Clin Pediatr (Phila)."},{"key":"10.4158\/EP14024.RA_bb0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0022-3476(05)81807-4","article-title":"Management of neonatal Graves disease with iopanoic acid","volume":"121","author":"Transue","year":"1992","journal-title":"J Pediatr."},{"key":"10.4158\/EP14024.RA_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.jp.7211046","article-title":"Iopanoic acid in the management of neonatal Graves\u2019 disease","volume":"24","author":"Earles","year":"2004","journal-title":"J Perinatol."},{"key":"10.4158\/EP14024.RA_bb0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1210\/jcem-65-4-679","article-title":"Long term treatment of Graves\u2019 disease with iopanoic acid (Telepaque)","volume":"65","author":"Wang","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/jcem-53-3-622","article-title":"Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol","volume":"53","author":"Sharp","year":"1981","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2265.1988.tb01217.x","article-title":"Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves\u2019 disease","volume":"28","author":"Roti","year":"1988","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14024.RA_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1986.tb01694.x","article-title":"Prolonged treatment of hyperthyroidism with sodium tyropanoate, an oral cholecystographic agent: a re-evaluation of its clinical utility","volume":"25","author":"Noguchi","year":"1986","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14024.RA_bb0145","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jcem-54-3-630","article-title":"Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism","volume":"54","author":"Wu","year":"1982","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2265.1985.tb00148.x","article-title":"Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves\u2019 disease","volume":"22","author":"Roti","year":"1985","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14024.RA_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03346928","article-title":"Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves\u2019 disease","volume":"9","author":"Robuschi","year":"1986","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP14024.RA_bb0160","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/BF03347940","article-title":"Therapy of Graves\u2019 disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism","volume":"14","author":"Martino","year":"1991","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP14024.RA_bb0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0026-0495(93)90094-5","article-title":"Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves\u2019 disease","volume":"42","author":"Roti","year":"1993","journal-title":"Metabolism."},{"key":"10.4158\/EP14024.RA_bb0170","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2265.1983.tb00040.x","article-title":"Effect of the combination of dexamethasone and sodium ipodate on serum thyroid hormones in Graves\u2019 disease","volume":"19","author":"Arteaga","year":"1983","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"10.4158\/EP14024.RA_bb0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03018544","article-title":"Rapid preparation of severe uncontrolled thyrotoxicosis due to Graves\u2019 disease with Iopanoic acid--a case report","volume":"51","author":"Pandey","year":"2004","journal-title":"Can J Anaesth."},{"issue":"5","key":"10.4158\/EP14024.RA_bb0180","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1210\/jc.2003-031981","article-title":"Rapid preoperative preparation for severe hyperthyroid Graves\u2019 disease","volume":"89","author":"Panzer","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"10.4158\/EP14024.RA_bb0185","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00005537-199708000-00012","article-title":"Sodium ipodate (oragrafin) in the preoperative preparation of Graves\u2019 hyperthyroidism","volume":"107","author":"Tomaski","year":"1997","journal-title":"Laryngoscope."},{"issue":"6","key":"10.4158\/EP14024.RA_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/thy.1995.5.469","article-title":"Coexistence of struma ovarii and Graves\u2019 disease","volume":"5","author":"Bayot","year":"1995","journal-title":"Thyroid."},{"issue":"5-6","key":"10.4158\/EP14024.RA_bb0195","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000181127","article-title":"Sodium ipodate in the preparation of Graves\u2019 hyperthyroid patients for thyroidectomy","volume":"31","author":"Berghout","year":"1989","journal-title":"Horm Res."},{"issue":"10","key":"10.4158\/EP14024.RA_bb0200","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1210\/jcem.86.10.7976","article-title":"Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism","volume":"86","author":"Chopra","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"10.4158\/EP14024.RA_bb0205","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2002-021874","article-title":"Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study","volume":"88","author":"Bogazzi","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"10.4158\/EP14024.RA_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF03343984","article-title":"Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy","volume":"25","author":"Bogazzi","year":"2002","journal-title":"J Endocrinol Invest."},{"issue":"6","key":"10.4158\/EP14024.RA_bb0215","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1067\/msy.2002.128561","article-title":"Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy","volume":"132","author":"Bogazzi","year":"2002","journal-title":"Surgery."},{"key":"10.4158\/EP14024.RA_bb0220","series-title":"Principles and practice of endocrinology and metabolism","first-page":"367","article-title":"Hyperthyroidism","author":"Burman","year":"1995"},{"key":"10.4158\/EP14024.RA_bb0225","first-page":"39","article-title":"Duenas A","volume":"21","author":"de Luis","year":"2004","journal-title":"An Med Interna."},{"key":"10.4158\/EP14024.RA_bb0230","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-3476(98)70332-4","article-title":"Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid","volume":"132","author":"Brown","year":"1998","journal-title":"J Pediatr."},{"key":"10.4158\/EP14024.RA_bb0235","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/BF03010940","article-title":"Thyrotoxicosis factitia in a postaortocoronary bypass patient","volume":"41","author":"Redahan","year":"1994","journal-title":"Can J Anaesth."},{"key":"10.4158\/EP14024.RA_bb0240","first-page":"99","article-title":"Sodium ipodate in the treatment of toxic diffuse goiter. Short-term and long-term effects on thyrotoxicosis","volume":"26","author":"Kamel","year":"1988","journal-title":"Endocrinologie."},{"key":"10.4158\/EP14024.RA_bb0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jfms.2011.02.003","article-title":"Efficacy of iopanoic acid for treatment of spontaneous hyperthyroidism in cats","volume":"13","author":"Gallagher","year":"2011","journal-title":"J Feline Med Surg."},{"key":"10.4158\/EP14024.RA_bb0250","first-page":"2178","article-title":"Use of sodium ipodate in management of hyperthyroidism in subacute thyroiditis","volume":"80","author":"Chopra","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0255","first-page":"53","article-title":"Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis","volume":"45","author":"Martinez","year":"2003","journal-title":"Panminerva Med."},{"key":"10.4158\/EP14024.RA_bb0260","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/jc.2003-031629","article-title":"Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid","volume":"89","author":"Dhillon","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-010-1362-z","article-title":"Outcomes of pregnancy complicated with hyperthyroidism: a cohort study","volume":"283","author":"Luewan","year":"2011","journal-title":"Arch Gynecol Obstet."},{"key":"10.4158\/EP14024.RA_bb0270","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline","volume":"97","author":"De Groot","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0275","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The Role of Propylthiouracil in the Management of Graves\u2019 Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid."},{"key":"10.4158\/EP14024.RA_bb0280","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","article-title":"Effect of atenolol on birth weight","volume":"79","author":"Lip","year":"1997","journal-title":"Am J Cardiol."},{"key":"10.4158\/EP14024.RA_bb0285","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198111263052205","article-title":"Current concepts: beta-blockers in pregnancy","volume":"305","author":"Rubin","year":"1981","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14024.RA_bb0290","series-title":"Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk","author":"Briggs","year":"1990"},{"key":"10.4158\/EP14024.RA_bb0295","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.1991.tb03562.x","article-title":"Rapid preoperative preparation in hyperthyroidism","volume":"35","author":"Baeza","year":"1991","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14024.RA_bb0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1148\/60.2.215","article-title":"A comparative clinical study of priodax and telepague, including 1,000 examinations","volume":"60","author":"Whitehouse","year":"1953","journal-title":"Radiology."},{"key":"10.4158\/EP14024.RA_bb0305","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(71)90474-0","article-title":"Cholecystography and renal failure","volume":"2","author":"Daymond","year":"1971","journal-title":"Lancet."},{"key":"10.4158\/EP14024.RA_bb0310","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0140-6736(71)90244-3","article-title":"Cholecystography and renal failure","volume":"2","author":"Mudge","year":"1971","journal-title":"Lancet."},{"key":"10.4158\/EP14024.RA_bb0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM196907102810207","article-title":"Brief recordings. Acute renal failure after the administration of iopanoic acid as a cholecystographic agent","volume":"281","author":"Canales","year":"1969","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14024.RA_bb0320","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jama.1977.03270310045006","article-title":"Thrombocytopenic purpura following iopanoic acid ingestion","volume":"237","author":"Hysell","year":"1977","journal-title":"JAMA."},{"key":"10.4158\/EP14024.RA_bb0325","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jama.1964.03070100065019","article-title":"Athrombocytosis following oral cholecystography","volume":"189","author":"Bishopric","year":"1964","journal-title":"JAMA."},{"key":"10.4158\/EP14024.RA_bb0330","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajh.2830140310","article-title":"Severe thrombocytopenia following oral cholecystography with iocetamic acid","volume":"14","author":"Insausti","year":"1983","journal-title":"Am J Hematol."},{"key":"10.4158\/EP14024.RA_bb0335","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1210\/jc.2005-0608","article-title":"Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial","volume":"90","author":"Bal","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0340","first-page":"1180","article-title":"The therapeutic efficacy of oral cholecystographic agent (iopanoic acid) in the management of hyperthyroidism","volume":"31","author":"Bal","year":"1990","journal-title":"J Nucl Med."},{"key":"10.4158\/EP14024.RA_bb0345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/thy.1991.1.143","article-title":"Further studies on the long-term treatment of Graves\u2019 hyperthyroidism with ipodate: assessment of a minimal effective dose","volume":"1","author":"Shen","year":"1991","journal-title":"Thyroid."},{"key":"10.4158\/EP14024.RA_bb0350","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jcem-47-6-1358","article-title":"The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism","volume":"47","author":"Wu","year":"1978","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14024.RA_bb0355","first-page":"215","article-title":"Resistant hyperthyroidism induced by sodium iopodate used as treatment for Graves\u2019 disease","volume":"120","author":"Caldwell","year":"1989","journal-title":"Acta Endocrinol (Copenh)."},{"key":"10.4158\/EP14024.RA_bb0360","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2265.1999.00822.x","article-title":"Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients","volume":"51","author":"Ramos-Dias","year":"1999","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14024.RA_bb0365","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1440-1681.2008.04966.x","article-title":"Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis","volume":"35","author":"Lizcano","year":"2008","journal-title":"Clin Exp Pharmacol Physiol."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/U25201800G3P3446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:50Z","timestamp":1761515870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20421032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1530891X20421032"],"URL":"https:\/\/doi.org\/10.4158\/ep14024.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Oral Cholecystographic Agents for the Management of Hyperthyroidism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14024.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}